Target intelligence / Profile preview

KAZN antisense RNA 1 (KAZN-AS1)

Target
KAZN-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA[1][3][2][5]
01

Overview

KAZN antisense RNA 1 (KAZN-AS1) is a long non-coding RNA (lncRNA) transcribed antisense to the KAZN gene in Homo sapiens[1][3]. Antisense lncRNAs like KAZN-AS1 are known to regulate gene expression at multiple levels, including via epigenetic mechanisms and transcriptional interference, often acting in cis to regulate the expression of their sense gene counterparts[2][5]. While the broader class of antisense lncRNAs may be involved in critical cellular processes such as development, carcinogenesis, and responses to external stimuli, and are under investigation as potential therapeutic targets or biomarkers, there are currently no published reports confirming specific biological functions, disease associations, or drug targeting relevant solely to KAZN-AS1.

Other names
ENST00000447908KAZN-AS1ENSG00000234593.4HSALNG0001020[1][3]
02

Mechanism of action

N/A for drugs, as no direct interacting drugs identified. General antisense lncRNA mechanisms include: Modulation of mRNA stability or translation; Chromatin remodeling; Transcriptional repression or activation in cis or trans[2][5].

03

Biological functions

Regulation of gene expressionEpigenetic regulation[2][5]Potential modulation of signaling pathwaysTranscriptional interference[5]
04

Disease associations

Cancer (potentially, based on antisense lncRNAs in general; no direct disease association confirmed for KAZN-AS1 specifically from current data)[2][5]

Beyond the preview

Go deeper on KAZN antisense RNA 1 (KAZN-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KAZN antisense RNA 1 (KAZN-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call